ELI LILLY & Co false 0000059478 0000059478 2021-05-27 2021-05-27 0000059478 us-gaap:CommonClassAMember 2021-05-27 2021-05-27 0000059478 lly:A1.000NotesDueJune22022Member 2021-05-27 2021-05-27 0000059478 lly:A718NotesDueJune12025Member 2021-05-27 2021-05-27 0000059478 lly:A1.625NotesDueJune22026Member 2021-05-27 2021-05-27 0000059478 lly:A2.125NotesDueJune32030Member 2021-05-27 2021-05-27 0000059478 lly:A625Notesdue2031Member 2021-05-27 2021-05-27 0000059478 lly:A6.77NotesDueJanuary12036Member 2021-05-27 2021-05-27 0000059478 lly:A1.700Notesdue2049Member 2021-05-27 2021-05-27





Washington, D.C. 20549







Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May 27, 2021




(Exact Name of Registrant as Specified in its Charter)




Indiana   001-06351   35-0470950
(State or Other Jurisdiction
of Incorporation)
File Number)
  (I.R.S. Employer
Identification No.)


Lilly Corporate Center

Indianapolis, Indiana

(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (317) 276-2000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report.)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class





Name of each exchange

on which registered

Common Stock (no par value)   LLY   New York Stock Exchange
1.000% Notes due 2022   LLY22   New York Stock Exchange
7 1/8% Notes due 2025   LLY25   New York Stock Exchange
1.625% Notes due 2026   LLY26   New York Stock Exchange
2.125% Notes due 2030   LLY30   New York Stock Exchange
0.625% Notes due 2031   LLY31   New York Stock Exchange
6.77% Notes due 2036   LLY36   New York Stock Exchange
1.700% Notes due 2049   LLY49A   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐




Item 8.01.

Other Events.

In May 2021, Eli Lilly and Company (“Lilly”) received a subpoena from the U.S. Department of Justice requesting the production of certain documents relating to its manufacturing site in Branchburg, New Jersey (“Branchburg”). Lilly is cooperating fully with the investigation.

Lilly had previously engaged external counsel to conduct an independent investigation of certain allegations relating to Branchburg. Lilly, through its counsel, is investigating these allegations thoroughly.

Lilly is deeply committed to manufacturing high-quality medicines for patients who need them, and the safety and quality of our products is our highest priority.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



/s/ Anat Hakim

Name:   Anat Hakim
Title:   Senior Vice President, General Counsel and Secretary
Date:   May 27, 2021